article thumbnail

Clarius Awarded FDA Clearance for AI Ultrasound Musculoskeletal Imaging App

HIT Consultant

What You Should Know: – Clarius Mobile Health , a leading provider of high-definition handheld ultrasound systems, receives 510(k) clearance for its new MSK AI model, which automatically identifies and measures tendons in the foot, ankle, and knee using artificial intelligence (AI).

FDA 94
article thumbnail

What Counts as a Psychedelic?

Bill of Health

Besides grants for “psychedelic” research, the FDA just released draft guidance on considerations for psychedelic clinical investigations with an ambiguous definition of what is considered to be a “psychedelic.” When we discuss FDA clinical trials , we’re talking big money , so clarity matters here.

FDA 191
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Recent FDA Enforcement Action Colors Regulatory Landscape for Delta-8 THC Products

Health Law Advisor

The Agricultural Improvement Act of 2018 (the “2018 Farm Bill”), which, among other things, offered a federal definition of hemp and removed it from the list of Schedule I controlled substances, specifically carved out hemp derived products with less than 0.3% 9-THC concentration of not more than 0.3 Fighting Cancer. ? The result?

FDA 52
article thumbnail

15-Second Heart Failure Test: Eko’s AI Stethoscope Gets FDA Nod

HIT Consultant

What You Should Know: – Eko Health , a provider of AI-powered heart and lung disease detection today announced FDA clearance for its Low EF detection AI. When the AI detects Low EF during a primary care exam, patients can be promptly referred to cardiology for definitive diagnosis and treatment planning.

FDA 40
article thumbnail

Psychedelic Lobbying and Regulatory Capture

Bill of Health

With this, we’re seeing active lobbying from stakeholders in the psychedelic realm on everything from telehealth to “psychedelic” definitions to research guidelines. But the most pertinent lobbying is currently working to shape the FDA’s guidelines for psychedelic therapy. MDMA-assisted therapy”).

FDA 135
article thumbnail

FDA Issues Draft Guidance on Labeling of Plant-Based Milk Alternatives

Health Law Advisor

Food and Drug Administration (“FDA”) announced a much-anticipated draft guidance regarding the naming and labeling of plant-based milk alternatives. [1] However, FDA found that consumers do not appear to understand the nutritional differences between plant-based milk and cow-derived milk. On February 22, 2023, the U.S.

FDA 52
article thumbnail

FDA and Digital Health Regulation

Health Blawg

The FDA had a digital health banner day on December 7, announcing one final guidance and two draft guidance documents (with a 60-day comment period). FDA has done a very good job of moving the ball forward, though there is certainly room for improvement, and there is opportunity for comment on two of the three guidance documents announced.

FDA 113